Carson Wealth (CWM LLC)
AMRX icon

Carson Wealth (CWM LLC)’s Amneal Pharmaceuticals AMRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Sell
32,063
-7
-0% -$94 ﹤0.01% 2182
2025
Q4 		$404K Buy
32,070
+2,840
+10% +$32.5K ﹤0.01% 2050
2025
Q3 		$293K Buy
29,230
+5,268
+22% +$47.3K ﹤0.01% 2155
2025
Q2 		$194K Buy
23,962
+8,882
+59% +$67K ﹤0.01% 2204
2025
Q1 		$126K Buy
15,080
+11,067
+276% +$92.4K ﹤0.01% 2234
2024
Q4 		$32K Buy
4,013
+270
+7% +$2.27K ﹤0.01% 3116
2024
Q3 		$31K Buy
3,743
+443
+13% +$3.46K ﹤0.01% 3063
2024
Q2 		$21K Buy
3,300
+360
+12% +$2.29K ﹤0.01% 3068
2024
Q1 		$18K Buy
2,940
+1,042
+55% +$5.88K ﹤0.01% 2958
2023
Q4 		$12K Buy
1,898
+376
+25% +$1.68K ﹤0.01% 3064
2023
Q3 		$6K Hold
1,522
– – ﹤0.01% 3344
2023
Q2 		$5K Sell
1,522
-1,116
-42% -$2.38K ﹤0.01% 3410
2023
Q1 		$4K Buy
2,638
+2,113
+402% +$4.21K ﹤0.01% 3350
2022
Q4 		$1K Sell
525
-2,312
-81% -$5.18K ﹤0.01% 3680
2022
Q3 		$6K Buy
+2,837
New +$7.95K ﹤0.01% 2941

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Carson Wealth (CWM LLC)'s AMRX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Amneal Pharmaceuticals (AMRX) stake by 0.02% in Q1 2026, selling an estimated $94 and leaving 32,063 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Carson Wealth (CWM LLC) first reported a position in AMRX in Q3 2022 and has held it in 15 quarters since. The position peaked at $404K in Q4 2025. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 32,063 shares of Amneal Pharmaceuticals worth $399K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 7 Amneal Pharmaceuticals shares in Q1 2026, an estimated $94.
  • Amneal Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2182 holding.
  • Carson Wealth (CWM LLC) first reported a position in Amneal Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Carson Wealth (CWM LLC)'s Amneal Pharmaceuticals position peaked at $404K in Q4 2025.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.